How to Calculate a Hospital Readmission Rate

A hospital readmission rate is, at its simplest, the number of patients who return to a hospital within a set period after discharge divided by the total number of eligible discharges. In practice, though, nearly every word in that definition hides a decision that changes the final number: which patients count, how long the window is, whether “planned” returns are stripped out, and whether you adjust for how sick people were in the first place. The formula looks straightforward on paper, but the choices behind it determine whether the rate you get is clinically meaningful or misleading.

The Basic Formula

The raw readmission rate is a proportion. You take the number of patients readmitted within a defined time window and divide it by the total number of index discharges during the measurement period, then multiply by 100 to get a percentage. An “index discharge” is the original hospitalization that starts the clock. If 130 out of 1,000 discharged patients come back within 30 days, your crude readmission rate is 13%.

That crude number is useful for internal tracking but not for comparing hospitals, because it ignores differences in how sick each hospital’s patients are. For comparison purposes, most payers and regulators use a risk-standardized readmission rate, which adjusts the raw count based on patient characteristics. The method the federal government uses for Medicare involves hierarchical logistic regression models that account for age, comorbidities, and other clinical factors, then compare each hospital’s predicted readmissions to its expected readmissions if the national average hospital had treated those same patients.

What Counts as a Readmission

Not every return trip to a hospital is treated as a readmission. The distinction between planned and unplanned readmissions matters enormously. An algorithm developed for Medicare’s readmission measures classifies certain admissions as inherently planned, including obstetric deliveries, maintenance chemotherapy, major organ transplants, and rehabilitation stays. Beyond those, a readmission is considered planned if it involves a scheduled procedure and is not triggered by an acute illness or a complication of care.¹ Complications of care, even when they include a procedure that could have been planned, stay in the unplanned column because they reflect a quality dimension worth measuring.

This classification is not always clean. A patient readmitted for a wound infection who then has a procedure to drain it could look “planned” if you only read the procedure code. The algorithm catches this by checking whether an acute diagnosis is also present. But coding inconsistencies across hospitals mean some planned readmissions slip through, and some unplanned ones get excluded. If you are calculating readmission rates internally, you need a clear local policy for flagging these cases and auditing the results.

Choosing the Time Window

The 30-day window is the standard in U.S. federal programs, but it is not the only option, and the window you pick changes what you find. In a study of patients after pancreatic surgery, a 30-day-from-discharge window captured about 74% of surgery-related readmissions, while a 90-day-from-surgery window caught 87%. The only factor independently associated with missed readmissions under the shorter window was major surgical complications.²

A similar pattern appears in spine surgery. Among patients who had lumbar procedures, about 9.4% were readmitted within 30 days, but the rate climbed to roughly 18% at 90 days. The reasons for coming back also shifted over time: pain and wound complications dominated in the first 30 days, while cardiovascular events became more prominent in the later window.³ The takeaway is that a 30-day window is convenient and widely accepted, but for surgical populations it can systematically miss late complications. If your goal is quality improvement rather than regulatory compliance, stretching to 90 days may give a more honest picture.

There is also a subtle but important distinction between “30 days from discharge” and “30 days from surgery.” A patient who has a long initial stay might be discharged on day 14 after surgery, so 30 days from discharge extends to day 44 post-operatively, while 30 days from surgery ends on day 30. For most medical admissions the difference is small, but for complex surgical cases it can meaningfully shift who gets counted.

Same-Hospital Versus All-Hospital Tracking

One of the biggest pitfalls in calculating readmission rates is counting only returns to the same hospital where the patient was originally treated. Patients who develop complications often end up at whichever hospital is closest, not necessarily the one that performed the original procedure. This is especially common when complex operations are centralized at tertiary centers but patients live closer to a community hospital.⁴

The gap between same-hospital and all-hospital rates is not trivial. In a study of surgical readmissions, the average all-hospital readmission rate was about 13%, while the same-hospital rate was roughly 8%. More strikingly, depending on the operation, between 57% and 63% of hospitals were reclassified into a different performance tier when profiling switched from same-hospital to all-hospital measurement.⁵ If your hospital tracks only its own returns, you are likely underestimating your true readmission rate and possibly misidentifying where your quality problems lie.

Linking data across hospitals requires access to claims data or a shared health information exchange. Medicare’s federal measures use all-hospital claims, which is one reason their numbers tend to run higher than what individual hospitals see in their internal dashboards. If you do not have access to claims-level data, at minimum acknowledge that your same-hospital rate is a floor, not a ceiling.

Who Gets Included and Who Gets Excluded

The denominator in a readmission rate calculation is just as important as the numerator, and standard exclusions can significantly change the result. Federal readmission measures typically exclude patients who died during the index hospitalization, patients with stays longer than 30 days, patients who left against medical advice, and patients who transferred to another acute care facility. In heart failure measures, patients who received a left ventricular assist device or a heart or lung transplant within 30 days are also excluded.⁶

These exclusions exist for good reason. A patient who dies in the hospital cannot be readmitted, so leaving them in the denominator would artificially deflate the rate. A patient transferred to another facility has not really been “discharged” in the usual sense. But each exclusion also creates a blind spot. Patients discharged against medical advice, for instance, are at very high risk of bouncing back, yet they vanish from the measure entirely. When building your own internal metric, you need to decide whether to follow standard exclusion rules or modify them based on what you are trying to learn.

Risk Adjustment and Why It Matters

A hospital that treats sicker, older, or more socially disadvantaged patients will almost always have a higher crude readmission rate than one that treats younger, healthier people. Risk adjustment is the statistical step that tries to level the playing field. Medicare’s approach uses hierarchical logistic regression models that adjust for age, race, dual-eligibility status, principal diagnosis, and about 30 comorbidity indicators drawn from claims in the year before admission.⁷ The model includes a random effect for each hospital, which prevents hospitals with small sample sizes from being unfairly tagged as outliers.

The output is a risk-standardized readmission rate, calculated as the ratio of predicted readmissions (including the hospital’s own effect) to expected readmissions (if a typical hospital had cared for those patients), multiplied by the national average readmission rate. If a hospital’s ratio is above 1.0, it is performing worse than expected given its patient mix. Below 1.0 means better than expected.

The problem is that even well-designed risk models leave a lot unexplained. For joint replacement patients, adding standard comorbidity indices to the base model barely moved the needle on prediction accuracy.⁸ And there is growing evidence that social determinants of health, things like poverty, housing instability, and food insecurity, drive readmissions in ways that clinical models do not capture.

The Social Determinants Problem

A systematic review of studies on Medicare’s Hospital Readmissions Reduction Program found that adding social risk factors to the base risk-adjustment model consistently reduced differences in penalties between safety-net hospitals and other hospitals.⁹ In other words, some of what looks like poor hospital performance is actually the result of caring for patients who face barriers to recovery that have nothing to do with clinical care.

Research using New York City hospital discharge data projected that including social determinants of health, especially at granular geographic levels, substantially changed which hospitals would face penalties. The continued omission of these variables from the federal model, the authors argued, effectively shifts penalties that should be attributed to social disadvantage onto the hospitals with the largest share of high-risk patients.¹⁰ A separate multicenter study of patients hospitalized for sepsis found that several social determinants were strongly associated with unplanned 30-day readmission and that prediction models improved when these factors were added to traditional clinical variables.¹¹

If you are calculating readmission rates for internal quality improvement, this matters. A spike in readmissions on a particular unit might reflect a change in the population you are serving rather than a decline in care quality. Without at least a rough adjustment for social risk, you might direct resources at the wrong problem.

The Observation Stay Loophole

One of the more contentious measurement issues is the treatment of observation stays. When a patient comes back to the hospital but is placed in “observation” status rather than formally admitted, that return does not count as a readmission under standard Medicare measures. As hospitals have increased their use of observation stays over the past decade, this creates a potential loophole: readmission rates can drop on paper without any actual improvement in patient outcomes.

Research quantifying this effect found that if observation stays were fully included in readmission calculations, roughly one in seven hospitals would switch from being classified as a high performer to a low performer, or the other way around. Safety-net hospitals and those with a higher tendency to use observation status performed significantly worse under the expanded definition.¹²

A separate analysis found that when observation stays were accounted for, the apparent reduction in readmission rates attributed to Medicare’s penalty program was more than halved. The readmission rate for targeted conditions dropped by less than one percentage point instead of the larger decline suggested by standard measures, and conditions not targeted by the program showed a similar decrease, suggesting the improvement was not specific to penalty incentives.¹³ That said, earlier cross-sectional work found only modest correlations between a hospital’s observation rate and its readmission rate for heart failure, heart attack, and pneumonia, with fewer than 4% of top-performing hospitals being reclassified when observation stays were included.¹⁴ The size of the observation stay effect likely depends on how aggressively a given hospital uses observation status.

Condition-Specific Versus Hospital-Wide Measures

You can calculate readmission rates for a specific condition, like heart failure, or across all admissions hospital-wide. These two approaches frequently disagree about which hospitals are performing well. In one analysis, among hospitals classified as poor performers by the heart failure readmission measure, only about 29% were similarly classified by the hospital-wide measure. The hospital-wide measure also penalized only 60% of hospitals that would have received penalties based on at least one condition-specific measure.¹⁵

This disconnect makes sense when you think about it. A hospital might have an excellent cardiology program with low heart failure readmissions but struggle with post-surgical infections that drive up its hospital-wide rate. The conditions targeted by the federal penalty program, including heart failure, heart attack, and pneumonia, represent less than 20% of all Medicare admissions.¹⁶ A hospital-wide measure captures a broader slice of care, but its statistical signal for any particular service line is diluted. The right choice depends on your purpose: condition-specific rates for targeted improvement work, hospital-wide rates for overall organizational benchmarking.

Readmission Penalties and Their Unintended Effects

Since 2012, Medicare’s Hospital Readmissions Reduction Program has penalized hospitals with higher-than-expected readmission rates by reducing their payments. The penalties are calculated by comparing a hospital’s risk-standardized readmission rate against the national average and can reduce Medicare reimbursement by up to 3% of base operating payments. Research has shown that readmission penalties track closely with excess readmissions but have almost no relationship to excess mortality. In nearly 2,000 U.S. hospitals, the correlation between penalties and excess readmissions was strong, but the correlation between penalties and excess combined readmission-and-mortality was only modest.¹⁷ This raises an uncomfortable question: could hospitals reduce readmissions by keeping sicker patients away from the hospital, potentially leading to worse outcomes that do not show up in the readmission metric?

The program also has a blind spot around Medicare Advantage. Because readmission rates are calculated using traditional Medicare fee-for-service claims, hospitals in areas with high Medicare Advantage enrollment have a smaller denominator, which makes their rate estimates less stable. One study found that adjusting for Medicare Advantage penetration would redistribute hundreds of millions of dollars in penalties annually, with hospitals in low-penetration areas facing higher penalties and those in high-penetration areas seeing relief.¹⁸

Safety-net hospitals, which serve disproportionately low-income and uninsured patients, have faced persistent concern about being unfairly penalized. The evidence on this is mixed: one analysis found that safety-net hospitals experienced only slightly higher penalties than other hospitals, but that finding has been contested by studies showing that social risk factors explain a meaningful share of the gap.¹⁹

Predicting Readmission Risk at the Patient Level

Beyond measuring rates at the hospital level, many organizations want to flag individual patients who are at high risk of coming back. The most widely used bedside tool for this is the LACE index, which scores patients on four factors: length of stay, acuity of the admission, comorbidities, and emergency department visits in the preceding six months. A meta-analysis found that the LACE index produced discrimination statistics ranging from modest to good across multiple chronic conditions, and that patients flagged as high-risk had meaningfully elevated readmission rates.²⁰ An extended version of the tool, the LACE+ index, adds more variables and showed stronger discrimination in a large validation study.²¹

These tools are useful for triaging transitional care resources, like scheduling a follow-up call for a high-risk patient within 48 hours of discharge, but they are far from perfect. A LACE score in the mid-range tells you a patient has elevated risk without telling you why. And at the hospital-wide level, even sophisticated predictive models built with electronic medical records achieved discrimination only modestly better than models built from administrative claims alone, with area-under-the-curve values of about 0.71 versus 0.70.²² Readmission, it turns out, is driven heavily by factors that neither clinical charts nor billing data capture well, including things like whether someone has a ride to their follow-up appointment or a stable place to recover.

How Other Countries Measure Readmissions

The 30-day, unplanned, risk-adjusted readmission rate tied to financial penalties is largely an American construct. A comparative review of readmission policies in Denmark, England, Germany, and the United States found considerable differences across countries in how readmissions are defined, which time windows are used, and whether financial consequences are attached.²³ England, for example, has used a 30-day emergency readmission measure but has applied payment reductions differently than the U.S. model. Germany has historically focused on readmissions within narrower surgical windows. Denmark tracks readmissions as a quality indicator without the same penalty structure.

These differences matter if you are benchmarking internationally or reviewing literature from other health systems. A “readmission rate” in a Danish study may not be comparable to one in an American study even if the numbers look similar, because the inclusion criteria, time windows, and adjustment methods differ. When reading published readmission rates, always check which country’s definition was used before drawing conclusions.

When Readmission Rates May Not Reflect Quality

There is a growing body of evidence suggesting that readmission rates, even after risk adjustment, are an imperfect proxy for hospital quality. The weak correlation between readmission penalties and mortality, noted in the penalty section above, is one piece of this puzzle. Another is the finding from bundled payment initiatives: most were not associated with significant changes in readmission or mortality rates, and among those that did show changes in readmissions, the results were mixed, with some bundled payment arrangements actually showing increases.²⁴

Some readmissions are genuinely preventable, like a patient sent home without clear medication instructions who ends up in crisis. But others reflect disease progression, patient preferences, or social circumstances entirely outside the hospital’s control. Treating the readmission rate as a pure quality measure can lead to perverse incentives: discouraging appropriate readmissions, shifting patients to observation status, or directing resources toward metric reduction instead of patient welfare. The rate is a useful signal, especially when tracked over time within a single institution, but it works best as one indicator among many rather than a standalone verdict on care quality.